| Product Code: ETC7655118 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of low molecular weight heparin to Israel saw a shift in concentration from moderate to high in 2024, with top exporting countries being Belgium, Switzerland, USA, Italy, and Germany. Despite a slight overall growth with a CAGR of 1.28% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024 at -12.32%. This change in dynamics suggests a potential reevaluation of market strategies and a need for closer monitoring of market trends to adapt to the evolving landscape in the low molecular weight heparin sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Low Molecular Weight Heparin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Low Molecular Weight Heparin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Low Molecular Weight Heparin Market - Industry Life Cycle |
3.4 Israel Low Molecular Weight Heparin Market - Porter's Five Forces |
3.5 Israel Low Molecular Weight Heparin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Low Molecular Weight Heparin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Low Molecular Weight Heparin Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Low Molecular Weight Heparin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring anticoagulant therapy, driving the demand for low molecular weight heparin products. |
4.2.2 Growing awareness among healthcare professionals and patients about the benefits of low molecular weight heparin over traditional heparin. |
4.2.3 Technological advancements in drug delivery systems improving the efficacy and safety profile of low molecular weight heparin. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new low molecular weight heparin products, leading to delays in market entry. |
4.3.2 Competition from alternative anticoagulant therapies such as novel oral anticoagulants (NOACs) impacting the market growth. |
4.3.3 Price fluctuations of raw materials used in the manufacturing of low molecular weight heparin affecting product pricing and profitability. |
5 Israel Low Molecular Weight Heparin Market Trends |
6 Israel Low Molecular Weight Heparin Market, By Types |
6.1 Israel Low Molecular Weight Heparin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Enoxaparin, 2021- 2031F |
6.1.4 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Dalteparin, 2021- 2031F |
6.1.5 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Tinzaparin, 2021- 2031F |
6.1.6 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.2 Israel Low Molecular Weight Heparin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Deep Vein Thrombosis, 2021- 2031F |
6.2.3 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Acute coronary syndrome (ACS), 2021- 2031F |
6.2.4 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Pulmonary Embolism, 2021- 2031F |
6.3 Israel Low Molecular Weight Heparin Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Israel Low Molecular Weight Heparin Market Revenues & Volume, By Ambulatory Surgical, 2021- 2031F |
7 Israel Low Molecular Weight Heparin Market Import-Export Trade Statistics |
7.1 Israel Low Molecular Weight Heparin Market Export to Major Countries |
7.2 Israel Low Molecular Weight Heparin Market Imports from Major Countries |
8 Israel Low Molecular Weight Heparin Market Key Performance Indicators |
8.1 Patient adherence rates to low molecular weight heparin therapy. |
8.2 Number of clinical trials exploring new indications or formulations for low molecular weight heparin. |
8.3 Adoption rates of low molecular weight heparin in various healthcare settings (hospitals, clinics, home care). |
9 Israel Low Molecular Weight Heparin Market - Opportunity Assessment |
9.1 Israel Low Molecular Weight Heparin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Low Molecular Weight Heparin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Low Molecular Weight Heparin Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Low Molecular Weight Heparin Market - Competitive Landscape |
10.1 Israel Low Molecular Weight Heparin Market Revenue Share, By Companies, 2024 |
10.2 Israel Low Molecular Weight Heparin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |